
Multiple Myeloma
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.

100% free · no login required
741 catalog rows—search by code, name, or category. Part 4 diagnostic codes open a schedule entry. Special monthly compensation rows are levels under 38 U.S.C. § 1114 and 38 CFR § 3.350, not Part 4 diagnostic codes.
Educational summaries last verified against eCFR Part 4: August 31, 2026

Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
Presumptive conditions covers Agent Orange, Gulf War, Camp Lejeune, radiation, cold injury, former POW, and the other presumptions listed on that page. It is an educational summary, not an eligibility decision.
VA may presume toxic exposure for service in listed locations during covered dates. Listed diagnoses are possible presumptive matches worth reviewing with a VSO. VA verifies the service and condition requirements.
The PACT Act expanded presumptions for specified respiratory conditions and cancers. VA still verifies that the diagnosis and the veteran's location, dates, and character of service meet the applicable requirements.

Asthma (diagnosed after service)
DC 660238 U.S.C. § 1120(b) / 38 CFR § 3.320
PACT Act §406 — must be diagnosed after service.


Chronic obstructive pulmonary disease (COPD)
DC 660438 U.S.C. § 1120(b)
PACT Act §406.
Constrictive bronchiolitis or obliterative bronchiolitis
38 U.S.C. § 1120(b)
Listed by VA for qualifying Gulf War era and post-9/11 service. Live 38 CFR § 4.97 DC 6825 is diffuse interstitial fibrosis, not bronchiolitis — no substitute diagnostic code is assigned here.

Chronic rhinitis
DC 652238 U.S.C. § 1120(b) / 38 CFR § 3.320(a)(2)
PACT Act §406. 38 CFR § 3.320(a)(2) also lists rhinitis.

Chronic sinusitis
DC 651338 U.S.C. § 1120(b) / 38 CFR § 3.320(a)(2)
PACT Act §406. 38 CFR § 3.320(a)(2) includes rhinosinusitis.

Granulomatous disease
38 U.S.C. § 1120(b)
PACT Act §406 — specific diagnostic code depends on the diagnosed disease.





Respiratory cancer of any type
DC 681938 U.S.C. § 1120(b) / 38 CFR § 3.320(a)(3)
Condition family. 38 CFR § 3.320(a)(3) names specific rare laryngeal, tracheal, and lung cancers inside this family. The diagnostic code depends on the diagnosed cancer.
Head cancer of any type
38 U.S.C. § 1120(b)
PACT Act §406 — condition family, DC assigned per specific cancer.
Neck cancer of any type
38 U.S.C. § 1120(b)
PACT Act §406 — condition family.
Gastrointestinal cancer of any type
38 U.S.C. § 1120(b)
Condition family; the diagnostic code depends on the diagnosed cancer.
Reproductive cancer of any type
38 U.S.C. § 1120(b)
Condition family; the diagnostic code depends on the diagnosed cancer.
Kidney cancer
38 U.S.C. § 1120(b)
PACT Act §406.
Brain cancer
38 U.S.C. § 1120(b)
PACT Act §406.
Glioblastoma
38 U.S.C. § 1120(b)
PACT Act §406.
Pancreatic cancer
38 U.S.C. § 1120(b)
PACT Act §406.

Melanoma
DC 783338 U.S.C. § 1120(b)(2)(I)
The statute says “Melanoma.” The schedule title is “Malignant melanoma,” DC 7833. The 2026-10-01 text of § 3.320 does not name melanoma. Section 3.309(e) does not name it. Section 3.320b does not name it.
Lymphoma of any type
38 U.S.C. § 1120(b)
38 U.S.C. § 1120(b)(2)(F) says “Lymphoma cancer of any type” and does not assign a diagnostic code. The schedule titles are separate: Hodgkin's lymphoma is DC 7709 and non-Hodgkin's lymphoma is DC 7715.
Lymphatic cancer of any type
38 U.S.C. § 1120
Listed with lymphoma on the VA Public Health PACT Act page.
Acute and chronic leukemias
38 CFR § 3.320b
Section 3.320b(b)(1) is acute leukemias and (b)(2) is chronic leukemias. The source note is 90 FR 1901, Jan. 10, 2025. The enumerated list in 38 U.S.C. § 1120(b)(2) does not use these words. Section 3.320 does not name them. The diagnostic code depends on the leukemia.

Multiple myeloma
DC 771238 CFR § 3.320b
Section 3.320b(b)(3) says “Multiple myelomas, including monoclonal gammopathy of undetermined significance (MGUS).” The source note is 90 FR 1901, Jan. 10, 2025. The enumerated list in 38 U.S.C. § 1120(b)(2) does not use the words “multiple myeloma.” Section 3.320 does not name it. The schedule code is DC 7712.
Myelodysplastic syndromes
DC 772538 CFR § 3.320b
Section 3.320b(b)(4) says “Myelodysplastic Syndromes (MDS).” The source note is 90 FR 1901, Jan. 10, 2025. The enumerated list in 38 U.S.C. § 1120(b)(2) does not use these words. Section 3.320 does not name them. The schedule title is “Myelodysplastic syndromes,” DC 7725.
Myelofibrosis
38 CFR § 3.320b
Section 3.320b(b)(5) names myelofibrosis. The source note is 90 FR 1901, Jan. 10, 2025. The enumerated list in 38 U.S.C. § 1120(b)(2) does not use this word. The schedule title at DC 7718 is essential thrombocythemia and primary myelofibrosis, so this row does not assign that code by itself.

Urinary bladder, ureter, and related genitourinary cancers
DC 752838 CFR § 3.320a
Section 3.320a names urinary bladder cancer, including over-lapping sites of the bladder, and ureter cancer. The source note is 90 FR 29, Jan. 2, 2025. Section 3.320 does not name these cancers. The authority line cites 38 U.S.C. 1119 and 1120.
Source reviewed 2026-10-05. Check this group’s current VA requirements.
The PACT Act added hypertension and monoclonal gammopathy of undetermined significance (MGUS) to VA’s Agent Orange presumptive-condition list.
These are herbicide-exposure presumptions, not burn-pit presumptions. VA verifies a recognized Agent Orange exposure location and dates plus a current diagnosis.

Hypertension
DC 710138 U.S.C. § 1116(a)(2)(M)
The statute names hypertension. The 2026-10-01 text of § 3.309(e) does not list hypertension as one of the herbicide diseases. Note 2 of that paragraph says ischemic heart disease does not include hypertension. Paragraph (a) lists cardiovascular-renal disease, including hypertension, as a separate chronic-disease group.

Monoclonal gammopathy of undetermined significance (MGUS)
DC 771238 U.S.C. § 1116(a)(2)(L)
The statute names monoclonal gammopathy of undetermined significance. The 2026-10-01 text of § 3.309(e) does not. Section 3.320b(b)(3) includes MGUS with multiple myelomas. DC 7712 places MGUS on the 0 percent line.
Source reviewed 2026-10-05. Check this group’s current VA requirements.
Conditions are researched individually; there is no bulk-add action.
Showing 1 of 1 matching entries

Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
Reviewed starting points
These links are starting points, not recommendations about what anyone should claim.
Disclaimer: Confirm every code and percentage in the current eCFR Part 4. This index is for education only.
⚠️ Important Disclaimer
This page provides general educational information based on public VA regulations and VA.gov resources. It is not legal or medical advice, and My Claim Packet is not a VA-accredited representative. Any worksheets or draft documents produced by the tools must be reviewed for accuracy and are not filed with VA for you. Ratings and service connection are decided case-by-case from the individual record. Consult a VA-accredited VSO, claims agent, attorney, or qualified clinician for help with your situation, and verify current rules using the linked official source.